The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


SmofKabiven Low Osmo Peripheral emulsion for infusion



Fresenius Kabi Deutschland GmbHPA2059/022/001

Main Information

Trade NameSmofKabiven Low Osmo Peripheral emulsion for infusion
Active SubstancesAlanine
Arginine
Glycine
Histidine
Isoleucine
Leucine
Lysine acetate
Methionine
Phenylalanine
Proline
Serine
Taurine
Threonine
Tryptophan
Tyrosine
Valine
Calcium chloride dihydrate
Sodium glycerophophate hydrate
Magnesium sulphate heptahydrate
Potassium chloride
Sodium acetate trihydrate
Zinc sulphate heptahydrate
Glucose monohydrate
Soya bean oil, refined
Triglycerides, medium chain
Olive oil, refined
Fish oil, rich in omega-3 acids
Dosage FormEmulsion for infusion
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/022/001

Group Information

ATC CodeB05BA Solutions for parenteral nutrition
B05BA10 combinations

Status

License statusAuthorised
Licence Issued26/04/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back